Proteomic study pinpoints potential biomarkers for long-COVID diagnosis and persistent health impacts

A two-year longitudinal study highlights proteomic changes in long-COVID patients, revealing potential biomarkers for diagnosis and shedding light on the persistent physiological challenges faced by survivors.

Tricuspid Valve Replacement Safe, Effective in Pivotal Trial

SAN FRANCISCO — The investigational Evoque transcatheter tricuspid valve replacement (TTVR) prosthesis appeared safe and beneficial in initial pivotal trial data. The major adverse event

October 28, 2023

EC approves BMS’ Camzyos for hypertrophic cardiomyopathy

The EC granted approval for Bristol Myers Squibb’s Camzyosb based on the positive safety and efficacy data from two Phase III trials. Credit: Bristol-Myers Squibb

June 27, 2023

Microvascular Diabetes Complications Linked to Moderate/Severe Gum Disease

Certain diabetes complications were linked to moderate and severe periodontitis, a cross-sectional analysis using Danish population-based data suggested. Among nearly 16,000 patients with type 2

September 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.